Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mirtazapine for Treatment of Cancer Associated Anorexia-cachexia : a Randomized Controlled Clinical Trial

NCT03254173 is registered in ClinicalTrials.gov with Catherine Naseef Hunter as lead sponsor.

NCT NCT03254173
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03254173 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mirtazapine for Treatment of Cancer Associated Anorexia-cachexia : a Randomized Controlled Clinical Trial
Lead sponsor
Catherine Naseef Hunter
Phase
Phase 2/3
Overall status
Completed
Start date
March 26, 2018
Completion date
October 17, 2019
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, cancer associated anorexia - cachexia